22 / 1851
Monoclonal antibodies
Small molecules
(e.g. tyrosine kinase inhibitors)
How do we target key structures?
|
|
22 / 1851
Monoclonal antibodies
Small molecules
(e.g. tyrosine kinase inhibitors)
How do we target key structures?